Jonathan Woodward

Jonathan Woodward

Auto-generated profile, based on publicly available information

Jonathan Woodward

Clinical Trials Research Unit, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2021 in Administration and Policy in Mental Health and Mental Health Services Research
Verified
Journal Article
Open access
PDF file
NFNick Firth
Nick Firth
MBMichael Barkham
Michael Barkham
JDJaime Delgadillo
Jaime Delgadillo
KAKai Allery
Kai Allery
JWJonathan Woodward
Jonathan Woodward
AOAlicia O’cAthain
Alicia O’cAthain
Dropout during psychological intervention is a significant problem. Previous evidence for associations with socioeconomic deprivation is mixed. This study aimed to review the evidence for associations between deprivation and dropout from contemporary adult psychological interventions for common mental disorders (CMDs). Systematic review, narrative synthesis and random effects meta-analysis of peer-reviewed English language journal articles published June 2010–June 2020 was conducted. Data sources included medline, PsycInfo, databases indexed by web of science, ProQuest social science database and sociology collection, and the Cochrane Library, supplemented by forward and backward citation searching. Five studies were eligible for inclusion (mean N = 170, 68% female, 60% White Caucasian, 32% dropout rate, predominantly cognitive behaviour therapy/cognitive processing therapy). Narrative synthesis indicated an overall non-significant effect of deprivation on dropout. Meta-analytic significance of controlled (k = 3) and uncontrolled (k = 4) effects depended on the measure of deprivation included for those studies using more than one measure (controlled OR 1.21–1.32, p = 0.019–0.172, uncontrolled OR 1.28–1.76, p = 0.024–0.423). The low number of included studies meant sub-group comparisons were limited, despite some tentative indications of potential differential effects. A comparator set of excluded studies showed similar uncertainty. There was limited evidence that did not overall suggest a clear significant effect of deprivation on dropout from contemporary individual CMD interventions. However, more contemporary research is needed, as effects may vary according to clinical and methodological factors, and for dropout versus non-initiation.

22 May 2024 in Public Health
Verified
Journal Article
Open access
ESElizabeth Such
Elizabeth Such
ICI. Campos-Matos
I. Campos-Matos
KHK. Hayes
K. Hayes
AMA. McCoig
A. McCoig
STS. Thornton
S. Thornton
JWJ. Woodward
J. Woodward

1 September 2025 in Health Expectations
Verified
Journal Article
Open access
KHKatie Hullock
Katie Hullock
AOAlicia O'CAthain
Alicia O'CAthain
FSFiona Sampson
Fiona Sampson
JWJonathan Woodward
Jonathan Woodward
ECElizabeth Coates
Elizabeth Coates
CMChristopher McDermott
Christopher McDermott
Objective: To explore intervention fidelity and experiences of using a new intervention designed to optimise calorie intake in people with amyotrophic lateral sclerosis (ALS). Methods: A mixed‐methods process evaluation was conducted alongside an ongoing randomised controlled trial across 15 ALS specialist centres in the United Kingdom. Data collection included 146 healthcare professional‐completed fidelity checklists, audio recordings of 5 intervention sessions, and qualitative interviews with 32 healthcare professionals, patients and informal caregivers. Results: Intervention fidelity was high (88%: 1059/1204 items completed by healthcare professionals). Healthcare professionals, patients and informal caregivers within the sample recognised the intervention's value and engaged with it. Patients were motivated to use the intervention because they believed it could slow disease progression, and it gave them a sense of control. Despite challenges with the intervention, including patient concerns about weight gain and physical limitations in food preparation and consumption, patients in this sample remained committed to using the intervention. However, healthcare professionals suggested that these challenges may have negatively influenced trial recruitment and retention. Caregivers played a crucial role in supporting patients emotionally and physically, helping them to adhere to the intervention. Conclusions: The intervention was feasible to implement and was delivered with fidelity. While patient engagement in this sample was strong, the intervention usability may be time‐limited as physical function declines. Therefore, the intervention may be best suited for those with slower‐progressing ALS who can manage the intervention and dietary changes. Moving forward, continued evaluation is needed to assess effectiveness and explore subgroup differences based on ALS type (slow vs. fast progressing). PPIE Contribution: PPI was integral to the process evaluation. PPI members reviewed key study documents, including the Participant Information Sheet and consent forms, leading to participant materials that were clear and easily understood. They also participated in developing the intervention. Trial Registration: IRAS ID 275949, ISRCTN30588041.

21 November 2025 in BMJ Open
Verified
Journal Article
Open access
KRKatie Ridsdale
Katie Ridsdale
JWJonathan Woodward
Jonathan Woodward
IAIfsah Asad
Ifsah Asad
BWBreesha Ward
Breesha Ward
DMDana Marbu
Dana Marbu
MRMichael Reddington
Michael Reddington
Objectives: Outcome measures used in sciatica research lack standardisation, making it difficult to combine data for analysis. This scoping review identified and categorised Patient Reported Outcome Measures (PROMs) employed in randomised controlled trials investigating sciatica interventions, providing a foundation for developing a consensus-based core outcome set. Design: Scoping review. Data sources: A systematic search was conducted across MEDLINE, Embase and Cochrane Central for research published between 1999 and 2024. Eligibility criteria: We included randomised controlled trials that involved patients with sciatica and used at least one PROM. Data extraction and synthesis: Screening and data extraction were performed independently by at least two reviewers. PROMs were categorised using the OMERACT Filter 2.0 framework, inductively sub-categorised into domains, and then the frequency was counted to identify patterns of use. Collection time points and intervention type were also assessed. Results: 187 studies met the inclusion criteria. These studies employed 69 different PROMs, collected 548 times across all papers. The Visual Analogue Scale for pain (n=115), Oswestry Disability Index (n=109) and Numeric Pain Rating Scale (n=74) were most frequently used. PROMs predominantly addressed the pathophysiological (n=274) and life impact (n=262) domains, with minimal attention to resource use/economic impact (n=12). Injection-based interventions were the most studied treatment approach. Follow-up periods using the same PROMs varied considerably between studies, with trends by intervention type. Conclusions: This review identified and categorised PROMs from numerous research studies, revealing substantial heterogeneity in outcome measurement for sciatica trials. This demonstrates the need for a standardised core outcome set. The predominance of use of non-sciatica-specific pain and disability measures suggests potential gaps in capturing sciatica-specific outcomes. Inconsistent follow-up durations and administration methods further highlight the requirement for standardisation.

1 March 2025 in Health and Social Care Delivery Research
Verified
Journal Article
Open access
CBChristopher Burton
Christopher Burton
CMCara Mooney
Cara Mooney
LSLaura Sutton
Laura Sutton
DWDavid White
David White
JDJeremy Dawson
Jeremy Dawson
VDVincent Deary
Vincent Deary
This article consists of a citation of a published article describing research funded by the Health and Social Care Delivery Research programme under project number 15/136/07, and is provided as as part of the complete record of research outputs for this project. The original publication is available at: https://doi.org/10.1016/j.pec.2023.107870 Objective: To describe the teaching and delivery of an extended consultation model designed for clinicians to use with patients with persistent physical symptoms and functional disorders. The model is underpinned by current scientific knowledge about persistent physical symptoms and the communication problems that arise in dealing with them. Methods: Process evaluation of training and delivery of the Recognition, Explanation, Action, Learning (REAL) model within the Multiple Symptoms Study 3: a randomised controlled trial of an extended-role GP “Symptoms Clinic”. Evaluation used clinician and patient interviews and consultation transcripts. Results: 7 GPs were trained in the intervention and 6 of them went on to deliver the REAL model in Symptoms Clinics either face-to-face or online. The Symptoms Clinic provided a set of 4 extended consultations to approximately 170 patients. Evaluation of training indicated that there was a considerable load in terms of new knowledge and skills. Evaluation of delivery found clinicians could adapt the model to individual patients while maintaining a high level of fidelity to its core components. Conclusion: REAL is a teachable consultation model addressing specific clinical communication issues for people with persistent physical symptoms. Practice implications: REAL enables clinicians to explain persistent physical symptoms in a beneficial way. Funding: This publication was funded by the Health and Social Care Delivery Research programme as a part of award number 15/136/07. This article reports on one component of the research award Multiple Symptoms Study 3: pragmatic trial of a community based clinic for patients with persistent (medically unexplained) physical symptoms. For more information about this research please view the award page [https://fundingawards.nihr.ac.uk/award/15/136/07] DOI: https://doi.org/10.1016/j.pec.2023.107870

1 April 2025 in Health and Social Care Delivery Research
Verified
Journal Article
Open access
CBChristopher Burton
Christopher Burton
CMCara Mooney
Cara Mooney
LSLaura Sutton
Laura Sutton
DWDavid White
David White
JDJeremy Dawson
Jeremy Dawson
VDVincent Deary
Vincent Deary
Background: People with multiple and persistent physical symptoms have impaired quality of life and poor experiences of health care. We aimed to evaluate the effectiveness of a community-based Symptoms Clinic intervention in people with multiple and persistent physical symptoms. Trial design: Pragmatic multicentre individually randomised parallel group clinical trial. Methods: Participants: Recruitment was between December 2018 and December 2021 in four areas of the UK. Eligibility was based on electronic health records, healthcare use and multiple physical symptoms (PHQ-15 between 10 and 20) which were not due to other medical conditions. Intervention delivery changed from face to face to online in 2020 in response to the pandemic. Interventions: Participants were randomised to receive the Symptoms Clinic plus usual care (intervention) or usual care alone (control). The Symptoms Clinic is a short-term extended medical consultation-based intervention delivered over approximately 8 weeks. Objective: To test the clinical and cost-effectiveness of an extended-role general practitioner ‘Symptoms Clinic’ for people with persistent physical symptoms. Outcome: The primary outcome measure was the PHQ-15 at 52 weeks post randomisation. Randomisation: Participants were randomised 1 : 1 using a centralised web-based system, stratified by study centre with random permuted blocks of varying sizes. Masking: It was not possible to mask participants to their allocation. Outcome assessors who handled patient-reported questionnaires were masked to allocation. Results: Numbers randomised: 354 participants were randomised into the trial: 176 to the usual care group and 178 to the intervention group. Numbers analysed: 132 participants in the usual care group and 144 participants in the intervention group were included in the analysis representing 77.8% retention. Outcome: Mean (SD) PHQ-15 at baseline was 14.9 (3.0) in the control group and 15.0 (2.9) in the intervention group. At 52 weeks it was 14.1 (3.7) in the control group and 12.2 (4.5) in the intervention group. The between-group difference, adjusted for age, sex, baseline PHQ-15 and clinician effect was −1.82 (95% CI −2.67 to −0.97; p < 0.001) favouring the intervention. Harms: There were no significant between-group differences in the proportions of patients experiencing non-serious (−0.03, 95% CI −0.11 to 0.05) or serious (0.02, 95% CI −0.02 to 0.07) adverse events. All serious adverse events were deemed unrelated to trial interventions. Economic evaluation: Cost-effectiveness analysis indicated an incremental cost-effectiveness ratio of £15,751/QALY. Process evaluation: The intervention was delivered with high fidelity and was acceptable to patients. The intervention appeared to act through the hypothesised mechanism of explanation as a bridge from uncertainty about the cause to actions to manage symptoms. Limitations and further research: The intervention was delivered by a small number of GPs in long consultations. Further research should examine wider implementation and how to integrate elements of the intervention into shorter consultations. Conclusions: The Symptoms Clinic delivered by specially trained GPs leads to a clinically meaningful improvement in physical symptoms at 52 weeks and is likely to be a cost-effective addition to current care. Funding: This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme as award number 15/136/07.